Advertisement
NeuroPace, Inc.

NeuroPace, Inc. (NPCE) Stock Overview

Explore NeuroPace, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NPCENASDAQ
HealthcareMedical - Devices
$16.47
$0.11(0.67%)
U.S. Market opens in 54h 50m
Advertisement

NeuroPace, Inc. (NPCE)

Meyka AI Score

Z

Key Financials

Market Cap560.2M
P/E Ratio-24.90
EPS (TTM)$-0.58
ROE-1.21%
Fundamental Analysis

AI Price Forecasts

1 Month$13.93
3 Months$13.60
1 Year Target$17.02

NPCE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeuroPace, Inc. (NPCE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $17.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -24.90 and a market capitalization of 560.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.43%
5-Day Change
5.59%
1-Month Change
-1.50%
3-Month Change
20.28%
6-Month Change
2.56%
Year-to-Date (YTD) Change
6.41%
1-Year Change
50.18%
3-Year Change
264.30%
5-Year Change
-29.03%
All-Time (Max) Change
-34.17%

Contact Information

650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

2,030 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions